A new regulator of PCSK9 and cholesterol synthesis, the PXR-SREBP2 pathway, also serves as a molecular mechanism for drug- and chemical-induced hypercholesterolemia.308. This evidence concerns the gene SREBF2 and familial hypercholesterolemia.